Theravance Biopharma, Inc.
€14.97
EUR
Last updated on --.
24h volume2.35M
24h highest14.9984 EUR
24h lowest14.9633 EUR
24h Price movement+0.06%
TBPH recent prices
24 Hours
+0.06%+€0.008789
30 days
-0.06%-€0.008789
60 days
+1.13%+€0.16699
90 days
+0.24%+€0.035156
Key data
Previous close14.9677 EUR
Market cap776.65M EUR
Volume2.35M
P/E ratio16.420000
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)0.91406 EUR
Net income (FY)47.29M EUR
Revenue (FY)91.68M EUR
Last report dateAug 11, 2026
About Theravance Biopharma, Inc.
HeadquartersGEORGE TOWN, GRAND CAYMAN
Employees (FY)90.00
Revenue per employee (FY)1.02M EUR
Net income per employee (FY)525.47K EUR
Listed onNasdaq
TBPH conversion tables
 |  |
|---|---|
| 0.5 TBPH | 7.488 EUR |
| 1 TBPH | 14.97 EUR |
| 5 TBPH | 74.88 EUR |
| 10 TBPH | 149.76 EUR |
| |
|---|---|
| 0.5 EUR | 0.033386 TBPH |
| 1 EUR | 0.066771 TBPH |
| 5 EUR | 0.33386 TBPH |
| 10 EUR | 0.66771 TBPH |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
TBPH is trading at €14.97, +0.06% over the last 24 hours. Track live moves on the price chart at the top of this page.
The TBPH stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. TBPH is currently trading at €14.97, +0.06% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on TBPH price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the PHARMACEUTICAL PREPARATIONS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. TBPH's P/E ratio is currently 16.420000 — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from TBPH; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against TBPH's historical range and other companies in the PHARMACEUTICAL PREPARATIONS sector.
Theravance Biopharma, Inc.'s market cap is currently 776.65M EUR. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume2.35M
24h highest14.9984 EUR
24h lowest14.9633 EUR
24h Price movement+0.06%
Start trade with TBPH Perpetual
Sign up to trade